微信小陈
微信小章| 产品名称： | Micromonospora chalcea (Foulerton) Orskov |
|---|---|
| 商品货号： | TS206607 |
| Strain Designations： | 1464-217L |
| Application： | Produces restriction endonuclease MchI |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Preceptrol®： | no |
| Type Strain： | yes (type strain) |
| Comments： | Oxidative conversion of 3-keto-nuclear-saturated steroids to corresponding delta 1,4-steroids compounds Colonial development |
| Medium： | ATCC® Medium 196: Yeast malt extract agar |
| Growth Conditions： | Temperature: 26.0°C |
| Name of Depositor： | Chas. Pfizer & Co., Inc. |
| References： | Shull GM. Preparation of 3-keto-delta1,4-steroids from 3-keto-delta4-steroids with Micromonospora. US Patent 2,809,919 dated Oct 15 1957 Shull GM. Preparation of delta1,4 steroid compounds by Micromonospora. US Patent 2,890,153 dated Jun 9 1959 Luedemann GM. Designation of neotype strains for Micromonospora coerulea Jensen 1932 and Micromonospora chalcea (Foulerton 1905) Orskov 1923. Int. J. Syst. Bacteriol. 21: 248-253, 1971. Suarez JE, Hardisson C. Morphological characteristics of colony development in Micromonospora chalcea. J. Bacteriol. 162: 1342-1344, 1985. PubMed: 3997781 Skerman VB, et al. Approved lists of bacterial names. Int J Syst Bacteriol 30: 225-420, 1980. type strain type strain |